Pricing Log in Create free account
Saturday 17 October 2026 Export BSX’s income statement to Excel — free account

Boston Scientific Corporation

BSX Healthcare Medical Devices

Boston Scientific Corporation’s revenue for fiscal 2025 (year ended December 2025) was $20.1 billion, up 19.9% from fiscal 2024. In the quarter to June 2026, revenue grew 7.53%, EPS grew 14.8%, free cash flow grew 13.3% and total debt rose 8.95%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for five consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.

44.39 0.25 +0.57%
Market cap
$64.0B
P/E
17.9×
Fwd P/E
17.8×
Dividend yield
—
F-score
7/9
Altman Z
5.41
Beneish M
−2.49
Dividend safety
n/a
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Boston Scientific Corporation (BSX) EV/EBITDA

Alert me on EV/EBITDA

As of 16 October 2026, Boston Scientific Corporation (BSX) trades at a EV/EBITDA of 13.9×. Over the past ten years it has ranged from 0.0× (September 2016) to 470× (September 2016); the current reading is higher than 16% of that period. That is above the Medical Devices industry median of 11.5× and above the Healthcare sector median of 9.2×.

EV/EBITDA, daily

Embed this chart

Annual newest first

Period EV/EBITDA Change
FY2025 30.0× (9.94%)
FY2024 33.3× 29.72%
FY2023 25.7× 1.30%
FY2022 25.3× (0.25%)
FY2021 25.4× (31.37%)
FY2020 37.0× (22.82%)
FY2019 47.9× 29.57%
FY2018 37.0× 18.66%
FY2017 31.2× (60.17%)
FY2016 78.3× —

Quarterly newest first

Period EV/EBITDA Change
Jun 2026 13.5× (31.52%)
Mar 2026 19.7× (34.43%)
Dec 2025 30.0× (3.82%)
Sep 2025 31.2× (15.25%)
42 more quarters

Against its own ten years

Low 0.0× High 470×
Ten-year median 32.8×
Current reading's percentile 16

EV/EBITDA against peers

Company EV/EBITDA
PHG Koninklijke Philips N.V. compare 8.8×
GEHC GE HealthCare Technologies Inc. compare 12.3×
BSX Boston Scientific Corporation 13.9×
STE STERIS plc compare 14.2×
MDT Medtronic PLC compare 14.5×
SYK Stryker Corporation compare 18.4×
ABT Abbott Laboratories compare 19.4×
DXCM DexCom, Inc. compare 23.5×
EW Edwards Lifesciences Corporation compare 29.0×
Medical Devices industry median 11.5×
Healthcare sector median 9.2×
Market median 11.0×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on BSX